A
4.75
0.09 (1.82%)
| Penutupan Terdahulu | 4.66 |
| Buka | 4.65 |
| Jumlah Dagangan | 188,215 |
| Purata Dagangan (3B) | 618,220 |
| Modal Pasaran | 1,478,547,456 |
| Harga / Pendapatan (P/E TTM) | 20.63 |
| Harga / Pendapatan (P/E Ke hadapan) | 10.89 |
| Harga / Jualan (P/S) | 2.67 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 18 Mar 2026 |
| Margin Keuntungan | 16.42% |
| Margin Operasi (TTM) | 7.97% |
| EPS Cair (TTM) | 0.370 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 260.00% |
| Pertumbuhan Pendapatan Suku Tahunan (YOY) | -65.50% |
| Nisbah Semasa (MRQ) | 1.73 |
| Aliran Tunai Operasi (OCF TTM) | -148.89 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -216.76 M |
| Pulangan Atas Aset (ROA TTM) | 7.02% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Drug Manufacturers - Specialty & Generic (US) | Bercampur | Menaik |
| Drug Manufacturers - Specialty & Generic (Global) | Menaik | Menaik | |
| Stok | Alvotech | Menurun | Menurun |
AISkor Stockmoo
-0.1
| Konsensus Penganalisis | 1.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | 0.5 |
| Purata Bergerak Teknikal | 0.0 |
| Osilator Teknikal | -2.0 |
| Purata | -0.13 |
|
Alvotech is an integrated biopharmaceutical company committed to developing and manufacturing high-quality biosimilar medicines for patients globally. its purpose is to improve the health and quality of life of patients around the world by improving access to treatments for various diseases. |
|
| Sektor | Healthcare |
| Industri | Drug Manufacturers - Specialty & Generic |
| Gaya Pelaburan | Small Growth |
| % Dimiliki oleh Orang Dalam | 63.44% |
| % Dimiliki oleh Institusi | 6.44% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Lodbrok Capital Llp | 30 Sep 2025 | 181,587 |
| Julat 52 Minggu | ||
| Julat Harga Sasaran | ||
| Tinggi | 10.00 (UBS, 110.75%) | Beli |
| Median | 8.00 (68.60%) | |
| Rendah | 5.00 (Barclays, 5.37%) | Jual |
| Purata | 7.67 (61.64%) | |
| Jumlah | 1 Beli, 1 Pegang, 1 Jual | |
| Harga Purata @ Panggilan | 5.17 | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| Barclays | 09 Dec 2025 | 5.00 (5.37%) | Jual | 5.56 |
| UBS | 18 Nov 2025 | 10.00 (110.75%) | Beli | 5.11 |
| Deutsche Bank | 04 Nov 2025 | 8.00 (68.60%) | Pegang | 4.83 |
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |